BMJ: New hypertension guidance has major implications for countries with low resources (3)

3 June, 2019

Thanks Neil, this is an interesting question. How to localise guidelines which draw on international evidence / best practice but are localised to suit the realities of different contexts? The PCI clinical team debated the new hypertension guidance at length recently in order to inform our own guidance – it is clear that what may be considered cost effective in one setting may not be cost effective in another setting – and the weight of actual clinical evidence is yet a different consideration. Anyone looking for help in developing locally appropriate clinical guidelines might be interested to read a recent blog which describes PCI’s iterative, collaborative approach to co-creation of clinical guidelines with the WHO and the MoH in South Sudan – feel free to contact me for more info.

Julia Beart

Chief Executive Officer

Primary Care International

Skype: juliabeart

Twitter: juliabeart

Primary Care International is a limited company registered in England and Wales. Registered number: 8924010. Registered office: Beaver House, 23-38 Hythe Bridge Street, Oxford, OX1 2ET. IMPORTANT: This message is intended for the addressee only and may contain private and confidential information or material which may be privileged. If this message has come to you in error you must delete it immediately and should not copy it or show it to any other person.

HIFA profile: Julia Beart works with Primary Care International, a social enterprise working to strengthen primary healthcare globally, with a particular focus on evidence-based medical education, training and systems change. Her professional interests include: healthcare innovation, approaches to health workforce training and retention, and models for partnership.